- Home
- CLNN vs PIII Comparison
CLNN vs PIII Comparison
Compare CLNN & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLNN
- PIII
- Stock Information
- Founded
- CLNN 2012
- PIII 2015
- Country
- CLNN United States
- PIII United States
- Employees
- CLNN N/A
- PIII N/A
- Industry
- CLNN Biotechnology: Pharmaceutical Preparations
- PIII Medical/Nursing Services
- Sector
- CLNN Health Care
- PIII Health Care
- Exchange
- CLNN Nasdaq
- PIII Nasdaq
- Market Cap
- CLNN 35.9M
- PIII 30.8M
- IPO Year
- CLNN N/A
- PIII N/A
- Fundamental
- Price
- CLNN $3.11
- PIII $0.18
- Analyst Decision
- CLNN Strong Buy
- PIII Hold
- Analyst Count
- CLNN 4
- PIII 2
- Target Price
- CLNN $55.25
- PIII $0.25
- AVG Volume (30 Days)
- CLNN 52.8K
- PIII 712.2K
- Earning Date
- CLNN 05-07-2025
- PIII 03-27-2025
- Dividend Yield
- CLNN N/A
- PIII N/A
- EPS Growth
- CLNN N/A
- PIII N/A
- EPS
- CLNN N/A
- PIII N/A
- Revenue
- CLNN $342,000.00
- PIII $1,500,455,000.00
- Revenue This Year
- CLNN N/A
- PIII $21.45
- Revenue Next Year
- CLNN $17,399.78
- PIII N/A
- P/E Ratio
- CLNN N/A
- PIII N/A
- Revenue Growth
- CLNN N/A
- PIII 18.48
- 52 Week Low
- CLNN $2.57
- PIII $0.15
- 52 Week High
- CLNN $9.20
- PIII $0.85
- Technical
- Relative Strength Index (RSI)
- CLNN 34.57
- PIII 50.69
- Support Level
- CLNN $2.57
- PIII $0.16
- Resistance Level
- CLNN $4.66
- PIII $0.19
- Average True Range (ATR)
- CLNN 0.33
- PIII 0.02
- MACD
- CLNN -0.13
- PIII 0.00
- Stochastic Oscillator
- CLNN 25.60
- PIII 68.26
Stock Price Comparison Chart: CLNN vs PIII
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.